REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431 | +8.8% | 15,587 | +5.3% | 0.00% | +33.3% |
| Q2 2023 | $396 | +89.5% | 14,800 | +53.4% | 0.00% | +50.0% |
| Q1 2023 | $209 | -13.6% | 9,649 | -4.9% | 0.00% | 0.0% |
| Q4 2022 | $242 | -99.9% | 10,146 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $197,000 | +21.6% | 9,965 | +20.2% | 0.00% | 0.0% |
| Q2 2022 | $162,000 | -15.6% | 8,292 | +10.2% | 0.00% | +100.0% |
| Q1 2022 | $192,000 | -52.9% | 7,522 | -53.5% | 0.00% | -50.0% |
| Q4 2021 | $408,000 | +81.3% | 16,176 | +97.6% | 0.00% | 0.0% |
| Q3 2021 | $225,000 | -19.1% | 8,187 | -6.4% | 0.00% | 0.0% |
| Q2 2021 | $278,000 | -0.4% | 8,748 | +44.0% | 0.00% | -80.0% |
| Q1 2021 | $279,000 | +16.7% | 6,075 | +0.7% | 0.01% | +11.1% |
| Q4 2020 | $239,000 | +14.4% | 6,031 | +0.6% | 0.01% | 0.0% |
| Q3 2020 | $209,000 | – | 5,998 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |